Your browser doesn't support javascript.
loading
Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes.
Roboz, Gail J; Yee, Karen; Verma, Amit; Borthakur, Gautam; de la Fuente Burguera, Adolfo; Sanz, Guillermo; Mohammad, Helai P; Kruger, Ryan G; Karpinich, Natalie O; Ferron-Brady, Geraldine; Acusta, Andre; Del Buono, Heather; Collingwood, Therese; Ballas, Marc; Dhar, Arindam; Wei, Andrew H.
Affiliation
  • Roboz GJ; Weill Cornell Medicine and New York-Presbyterian Hospital, New York, NY, USA.
  • Yee K; Princess Margaret Cancer Center, Toronto, ON, Canada.
  • Verma A; Montefiore Medical Center and Albert Einstein College of Medicine, New York, NY, USA.
  • Borthakur G; MD Anderson Cancer Center, Houston, TX, USA.
  • de la Fuente Burguera A; MD Anderson Cancer Center, Madrid, Spain.
  • Sanz G; Department of Hematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain.
  • Mohammad HP; GSK, Collegeville, PA, USA.
  • Kruger RG; GSK, Collegeville, PA, USA.
  • Karpinich NO; GSK, Collegeville, PA, USA.
  • Ferron-Brady G; GSK, Collegeville, PA, USA.
  • Acusta A; GSK, Collegeville, PA, USA.
  • Del Buono H; GSK, Collegeville, PA, USA.
  • Collingwood T; GSK, Collegeville, PA, USA.
  • Ballas M; GSK, Collegeville, PA, USA.
  • Dhar A; GSK, Collegeville, PA, USA.
  • Wei AH; Alfred Hospital and Monash University, Melbourne, VIC, Australia.
Leuk Lymphoma ; 63(2): 463-467, 2022 02.
Article in En | MEDLINE | ID: mdl-34927529

Full text: 1 Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Year: 2022 Type: Article